Enveric Biosciences Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Enveric Biosciences, Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Revenue & Gross Profit
Revenue0.000.000.000.000.00
Cost of Revenue0.340.000.000.000.00
Gross Profit-0.340.000.000.000.00
Operating Expenses
Research & Development2.847.258.034.790.17
Selling, General & Administrative6.458.8511.6121.625.32
Operating Expenses9.2916.4519.9627.075.62
Operating Income-9.63-16.45-27.42-27.07-5.62
Other Income/Expense
Interest Income0.000.000.000.000.00
Interest Expense0.000.00-0.010.01-0.45
Other Income/Expense0.07-1.030.01-29.35-0.80
Income
Income Before Tax-9.57-17.26-19.96-56.43-6.86
Income Tax Expense0.010.03-1.49-7.450.00
Net Income-9.57-17.29-18.50-48.98-6.86
Net Income - Continuous Operations-9.57-17.29-18.47-48.980.00
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA-9.23-17.27-19.52-55.74-5.50
EBIT-9.57-17.27-19.95-56.42-5.62
Depreciation & Amortization0.340.340.330.660.12
Earnings Per Share
Basic EPS-228.00-121.00-13.00-18664.00-
Diluted EPS-228.00-121.00-13.00-18664.00-
Basic Shares Outstanding0.040.141.450.030.00
Diluted Shares Outstanding0.040.141.450.030.00